As digital therapeutics continue to evolve and prove their clinical efficacy, health care organizations face both exciting opportunities and complex challenges in adoption and reimbursement. This session will explore the current landscape of digital therapeutics (DTx), with a focus on how executives can strategically integrate these tools into care delivery while navigating the evolving reimbursement models.
Attendees will gain insight into:
- The role of digital therapeutics in enhancing patient outcomes in behavioral health, chronic disease, and preventative care
- Current regulatory frameworks and FDA-cleared DTx pathways
- Key partnerships, billing codes, and documentation practices that drive financial sustainability